Since the FDA clearance of NeuroStar Advanced Therapy TMS in 2008, insurance coverage for eligible patients has increased significantly. Currently, there are over 60 coverage polices for NeuroStar Advanced Therapy TMS, including most Medicare contractors. Although NeuroStar Advanced Therapy TMS is not a first line of treatment, it is an alternative option for those who are not responding to or cannot tolerate medications.